SCHEMBL4638753

SCHEMBL4638753

O=S(=O)(NC1Cc2ccccc2C1)c1cccc(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 4/20 0.50
PSEN2 P49810 4/20 0.50
APH1B Q8WW43 4/20 0.50
NCSTN Q92542 4/20 0.50
APH1A Q96BI3 4/20 0.50
PSENEN Q9NZ42 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
APOB P04114 1/20 0.46
MTTP P55157 1/20 0.46
ALDH1A1 P00352 5/20 0.44
LMNA P02545 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
TSHR P16473 2/20 0.44
THRB P10828 1/20 0.44
BRD4 O60885 1/20 0.44
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5822058 0.85 PSEN1 (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7453062 0.82 HDAC8 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4638257 0.81 SFRP1 (0.54) MEN1KMT2ACA1CA2ALDH1A1
SCHEMBL4637123 0.79 SFRP1 (0.65) KMT2AALDH1A1LMNANPSR1TSHR
SCHEMBL1403037 0.79 HDAC3 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4638779 0.79 SFRP1 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1403038 0.79 HDAC3 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4639128 0.78 L3MBTL1 (0.50) MEN1KMT2ACA1CA2TSHR
SCHEMBL4618892 0.78 SFRP1 (0.72) WNT3SFRP1
SCHEMBL1403209 0.77 KMT2A (0.49) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PSEN1 126/4885PSEN2 516/4885APH1B 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.